Coriolis Pharma has opened a new U.S. headquarters and laboratory at the Alexandria Center for Advanced Technologies (ACAT) in North Carolina’s Research Triangle Park (RTP). This expansion enables Coriolis to provide its North American clients with direct access to specialized expertise in formulation and drug product development as well as analytical characterization of biopharmaceutical products.

The new site offers particle analysis and fast track analytics, formulation development, and drug product development. The services will be rolled out progressively throughout 2026, with all capabilities available by Q4 2026.

“Opening our lab and U.S. Headquarters in North Carolina is a major leap forward for Coriolis. It fuels our mission to empower innovation where it happens,” said Silvia Steyrer‑Gruber, CEO of Coriolis Pharma. “The region’s scientific excellence, cutting‑edge biotech and manufacturing ecosystem and collaborative energy make it the perfect home for our next chapter.”

“We are excited to bring our deep scientific expertise and comprehensive service offerings to the vibrant life science community in North Carolina,” added John Gabrielson, President of Coriolis Pharma U.S. Inc. “Together with our colleagues in Germany and partners worldwide, we will deliver solutions that meet the highest quality standards – empowering companies in the U.S. to accelerate their development programs and drive innovation forward.”